Clinical application of stress echocardiography in valvular heart disease by unknown
KARDIOLOGIA POLSKA 2020; 78 (6)632
Correspondence to: 
Patrycjusz Stokłosa, MD, PhD, 
Department of Valvular 
Heart Disease, National 
Institute of Cardiology, 
ul. Alpejska 42, 04-628 Warszawa, 
Poland, phone: +48 22 343 46 46, 
email: pstoklosa@ikard.pl
Received: May 15, 2020.
Accepted: May 16, 2020.
Published online: May 18, 2020.
Kardiol Pol. 2020; 78 (6): 632-641
doi:10.33963/KP.15360
Copyright by the Polish Cardiac 
Society, Warsaw 2020
AbstrAct
Valvular heart diseases (VHDs) constitute an increasing problem both as a consequence of population aging 
and as the sequelae of other heart diseases. Accurate diagnosis is essential for correct clinical decision ‑making; 
however, in many patients, transthoracic and transesophageal echocardiography is insufficient. Stress 
echocardiography (SE) proved to be a useful tool allowing for simultaneous assessment of left ventricular 
contractile reserve and HVD hemodynamics under conditions of physiological or pharmacological stress. It 
is recommended for assessing the severity of VHD, guiding the choice of treatment, as well as for surgical 
risk stratification. It can be applied both in asymptomatic patients with severe VHD and in symptomatic 
individuals with moderate disease. In patients with VHD, SE can be performed either as exercise stress 
echocardiography (ESE) or dobutamine stress echocardiography (DSE). The first modality is recommended 
to unmask symptoms or abnormal blood pressure response in patients with aortic stenosis (AS) who report 
to be asymptomatic or in those with mitral stenosis with discordance between clinical symptoms and 
the severity of valve disease on transthoracic echocardiography. In asymptomatic patients with paradoxical 
low ‑flow, low ‑gradient (LFLG) AS, ESE can be used to assess the severity of stenosis. On the other hand, 
low ‑dose DSE can be a useful diagnostic tool in classical LFLG AS, providing information on stenosis severity 
and contractile reserve. Moreover, SE is indicated in patients with prosthetic valve when there is discordance 
between symptoms and echocardiographic findings. It is also recommended in high ‑risk surgical patients 
with VHD with poor functional capacity and more than 2 clinical risk factors. The present paper discusses in 
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strong coffee, tea, or other energy drinks, as 
well as smoking. Discontinuation of medications 
masking the symptoms or affecting the test re-
sult (eg, β-blockers, nitrates) may be considered 
prior to testing. Patients should provide written 
informed consent to undergo the examination. 
Before the examination, resting echocardi-
ography should be performed to assess the qual-
ity of the images. If echogenicity is decreased, 
the reliability of the test is questionable and SE 
is not recommended in such patients. The choice 
of a stress test modality depends on the presence 
of indications and contraindications as well as 
the physician’s experience and preference.
Stress echocardiography was confirmed to be 
safe.8,9 The safety of exercise SE (ESE) is compa-
rable to that of a standard exercise stress test. As 
for DSE, the most common adverse effects include 
trembling, flushing, headaches, and palpitation.
stress echocardiography protocols in valvu‑
lar heart disease Valvular heart disease is 
diagnosed using ESE and DSE.3,7 The choice of 
the modality and protocol depends on indica-
tions and the patient’s clinical status. Consider-
ing the very short duration of imaging, it is im-
portant to predefine the echocardiographic pa-
rameters and to acquire the images in a specific 
order depending on the aim of the test. During 
SE, blood pressure monitoring, 12-lead electro-
cardiogram recording, and assessment of clini-
cal status are mandatory.
Exercise SE requires the patient’s coopera-
tion and ability to perform physical exercise. It 
is a symptom -limited test conducted using a semi-
-supine bicycle or treadmill. Semi -supine bicycle 
exercise echocardiography allows detailed image 
acquisition throughout the test, from low to peak 
workload. The patient pedals at a constant cadence 
(60 rpm) against the increasing workload (starting 
at 25 W with increments of 25 W at 3-minute in-
tervals). The images are acquired at baseline, at 25 
to 50 W, on achieving a heart rate of 100 to 120 
bpm, at peak stress, and during recovery. In se-
vere valve disease, LV images should be acquired 
first to assess contractile reserve and changes in 
global longitudinal strain (GLS). In contrast, in 
asymptomatic patients with LFLG AS with pre-
served LVEF, images allowing the assessment of 
disease severity and LV flow reserve should be ac-
quired first. The semi -supine bicycle is the only 
ESE modality that enables the estimation of sys-
tolic pulmonary artery pressure (SPAP) by assess-
ing TR. Treadmill exercise is another ESE modal-
ity, but it does not allow imaging during exercise. 
Images are typically acquired after peak exercise 
(within 90 seconds after termination), immedi-
ately after the patient has been moved to an echo-
cardiography bed. Therefore, this modality can-
not be used to identify abnormalities at low work-
load. The commonly used treadmill protocols are 
the Bruce and modified Bruce protocols.
Introduction The first Polish registry of echo-
cardiography studies (Pol -STRESS [Polish Stress 
Echocardiography Registry]) and a European 
report on cardiac imaging studies show that 
stress echocardiography (SE) is currently a well-
-recognized imaging modality, predominantly 
used in the diagnosis of coronary artery disease 
and valvular heart disease (VHD).1,2 It is currently 
recommended by numerous guidelines of the Eu-
ropean Society of Cardiology (ESC) as a nonin-
vasive test with high sensitivity and specificity. 
The test uses various stressors (most often exer-
cise and dobutamine) that enhance left ventricu-
lar (LV) contractility, increase blood flow through 
the valve orifices, or lead to an imbalance between 
myocardial oxygen supply and demand. Stress-
-induced ischemia generates new or worsening 
regional wall motion abnormalities as well as 
changes in blood flow through the heart valves.3
For more than a decade, Polish4 and Europe-
an5 experts in cardiac imaging as well as the ESC 
guidelines for the management of patients with 
VHD6 have recommended the use of SE for as-
sessing the severity of VHD, guiding the choice 
of treatment, and for surgical risk stratification. 
The examination is indicated in asymptomat-
ic patients with severe VHD or in symptom-
atic individuals with moderate disease. A spe-
cial group of patients are those with low -flow, 
low -gradient (LFLG) aortic stenosis (AS) and 
reduced LV ejection fraction (LVEF) as well as 
those with so -called paradoxical LFLG AS in 
which LVEF is preserved. Stress echocardiogra-
phy is also recommended in patients with mi-
tral stenosis (MS) as well as mitral (MR) and tri-
cuspid regurgitation (TR). Finally, it may be per-
formed to identify patients at increased risk of 
pulmonary hypertension.7
stress echocardiography: laboratory equip‑
ment and patient preparation The SE labo-
ratory should be equipped with a resuscitation 
kit containing an automated external defibril-
lator, a bag valve mask, and basic emergency 
drugs with infusion fluids. β -Blockers or nitro-
glycerin should be available to reverse dobuta-
mine action. Blood pressure monitors and elec-
trocardiogram machines are also indispensable.
Before SE, it is important to collect detailed 
medical history, including contraindications 
to the examination. Stress echocardiography 
should not be performed in patients with un-
stable coronary artery disease, decompensat-
ed heart failure, severe arrhythmia, myocardi-
tis, endocarditis, and pericarditis, while con-
traindications to dobutamine SE (DSE) include 
uncontrolled high blood pressure and hyper-
trophic cardiomyopathy with high LV outflow 
tract (LVOT) gradient. The examination should 
be done in a fasting state or at least 4 hours af-
ter a light meal. Before the examination, pa-
tients should avoid physical exertion, drinking 
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is a predictor of high perioperative mortality.12 
However, it should be emphasized that this ab-
normality does not preclude an improvement 
in the patient’s clinical status and late survival 
after surgical or transcatheter aortic valve re-
placement. Therefore, the absence of LV flow re-
serve on DSE should not preclude consideration 
for aortic valve replacement.3,12
In some patients, a  discordance between 
a small AVA and low gradient is maintained 
throughout DSE, making it difficult to determine 
the severity of stenosis. In this population, typ-
ically presenting with not sufficient increase in 
transvalvular flow rate, the so called projected 
AVA can be calculated, which provides an esti-
mate of the AVA at normal transvalvular flow 
rate (ie, 250 ml/s),10,13 using the following formula: 
Projected AVA = AVArest + (ΔAVA/ΔQ) × (250–Qrest)
where AVArest and Qrest are the AVA and mean 
transvalvular flow rate (ie, SV/LV ejection time) 
measured at rest, while ΔAVA and ΔQ are the ab-
solute changes in the AVA and mean transvalvu-
lar flow rate measured during DSE. To obtain a re-
liable measurement of the projected AVA, a mini-
mum increase of 15% (optimally ≥20%) in trans-
valvular flow rate during dobutamine infusion is 
required.12 A projected AVA of less than 1 cm2 con-
firm the presence of true -severe AS.
In patients with classical LFLG AS, in whom 
DSE cannot be used to differentiate between 
true- and pseudo -severe stenosis because of in-
adequate increase in transvalvular flow rate, 
multidetector computed tomography (MDCT) 
should be applied to assess aortic valve calcifi-
cation (FIGURE 1).3,10
Paradoxical low ‑flow, low ‑gradient aortic stenosis 
Currently, DSE is not recommended as a diag-
nostic tool in paradoxical LFLG AS because of 
limited evidence and an increased risk of he-
modynamic abnormalities due to dobutamine-
-induced abnormal LV filling pressure, LVOT ob-
struction, and subsequent hypotension in pa-
tients who typically have pronounced LV concen-
tric remodeling with a small LV cavity size and 
restrictive physiology pattern.10,11 The gold stan-
dard for assessing stenosis severity in this pop-
ulation is MDCT (FIGURE 1), while ESE can be used 
in patients with no or mild symptoms.
Before using additional tests, it is important 
to note that resting AVA in patients with trans-
valvular flow rate exceeding 200 ml/s is unlike-
ly to change during stress.14
stress echocardiography in patients with 
asymptomatic severe aortic stenosis 
Recommendations Patients with severe high-
-gradient AS, defined as an AVA of less than 1 cm2 
and a mean pressure gradient (MPG) exceeding 
40 mm Hg at rest, who present with symptoms 
(class I, level of evidence B) and / or LV systolic 
Dobutamine SE allows image acquisition at low, 
intermediate, and peak levels of stress. The DSE 
protocol involves continuous intravenous dobuta-
mine infusion, starting at a dose of 5 µg/kg/min, 
uptitrated by 5 to 10 µg/kg/min every 3 to 8 min-
utes, up to 40 µg/kg/min. The maximum dose in 
the assessment of patients with AS is 20 µg/kg/min. 
Image acquisition should start 2 to 3 minutes af-
ter each increment of dobutamine dose. Due to 
the vasodilatory effect of dobutamine, DSE does 
not allow an assessment of SPAP and MR severity.
Stress echocardiography in low ‑flow, low‑
‑gradient aortic stenosis Low -flow, low-
-gradient AS is defined as the presence of a mean 
transvalvular gradient of less than 40 mm Hg, 
an  effective aortic valve area (AVA) of less 
than 1 cm2 (0.6 cm2/m2 body surface area), and 
a stroke volume (SV) index of less than 35 ml/m2. 
It may be classic (with reduced LVEF) or para-
doxical (with preserved LVEF).
Low -dose DSE can be a useful diagnostic tool 
in classical LFLG AS, providing information on 
stenosis severity (changes in the mean trans-
valvular gradient and AVA in response to the in-
crease in flow rate) and LV contractile reserve 
(changes in SV and LVEF). The DSE protocol for 
the assessment of classical LFLG AS starts at a 
low dobutamine dose of 2.5 or 5 µg/kg/min, up-
titrated at 3- to 5-minute increments to a maxi-
mum dose of 20 µg/kg/min.10 High doses should 
be avoided due to the increased risk of arrhyth-
mia and possible overestimation of stenosis se-
verity during the accelerated flow rate caused 
by high drug concentrations.10
The minimum acquired dataset at baseline 
and at each stage of infusion should include 
aortic flow velocity measured with continuous-
-wave Doppler (optimally recorded from the win-
dow with the highest velocity signal), LVOT flow 
velocity measured with pulsed -wave Doppler, 
and LV contractile reserve assessed in the para-
sternal long -axis and apical 4- and 2-chamber 
views. The LVOT diameter is measured at base-
line, and the value is used to calculate the AVA by 
the continuity equation throughout the test.3,10 
A DSE report should include peak transvalvu-
lar flow velocity, mean gradient, SV, and AVA 
at each stage of the test; LVEF should be mea-
sured at least at baseline and at peak stress.
Classical low ‑flow, low ‑gradient aortic stenosis 
Clinically significant findings of DSE in classi-
cal LFLG AS are as follows:10,11
1	 an increase in the mean transaortic gradient 
above 30 mm Hg (optimally >40 mm Hg) with 
an AVA of less than 1 cm2 at any stage of dobu-
tamine infusion, which indicates true -severe AS;
2	 an increase in AVA above 1 cm2, which indi-
cates absence of severe stenosis;
3	 no increase in SV to 20% or higher indicat-
ing the lack of contractile (flow) reserve, which 
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image acquisition throughout the test as it does 
not require the change of the patient’s posi-
tion.3,7 Imaging at low workload allows an as-
sessment of contractile reserve and changes 
in GLS, which may reveal subclinical LV sys-
tolic dysfunction.7
Interpretation of the test Echocardiographic 
parameters that should be assessed during ESE 
are shown in TABLE 1.
Global longitudinal strain seems to outweigh 
LVEF in terms of predicting symptoms and car-
diovascular events in patients with asymptomat-
ic severe high -gradient AS with preserved LVEF, 
although the precise cutoff values have not yet 
been determined.3,6
Definitions of abnormal results and the cut-
off values for clinical and echocardiographic pa-
rameters are presented in TABLE 2.
Impact on management Therapeutic decision-
-making in patients with asymptomatic severe 
AS who undergo ESE is presented in TABLE 3.
stress echocardiography in aortic regurgi‑
tation Surgical aortic valve replacement is 
indicated in patients with symptomatic severe 
aortic regurgitation (AR; class I indication, lev-
el of evidence B).6
Clinical indications In patients with severe AR 
who report to be asymptomatic, exercise testing 
dysfunction (class I, level of evidence C) should 
be referred for surgical aortic valve replacement 
(SAVR) or, in some cases, for transcatheter aor-
tic valve implantation.6 In patients with asymp-
tomatic AS, an exercise stress test is recommend-
ed to reveal symptoms or abnormal blood pres-
sure response to exercise.3,6 However, the exer-
cise test does not always allow to detect every 
high-risk patient with asymptomatic AS; there-
fore, other diagnostic tools are being sought. Im-
portantly, the exercise test is contraindicated in 
symptomatic patients with severe AS.3
Clinical indications In patients with asymptom-
atic severe paradoxical LFLG AS, SE can be used 
to determine stenosis severity.7,16 In physical-
ly active patients with severe AS, ESE has been 
shown to be useful for unmasking symptoms 
and for risk stratification.15
Test parameters	 Modalities	 In patients with as-
ymptomatic AS, ESE can be performed using 
either a treadmill or bicycle ergometer proto-
col. Dobutamine SE is contraindicated in severe 
high -gradient AS and not recommended in par-
adoxical LFFG AS.7
Protocols The commonly used treadmill pro-
tocols are the Bruce and modified Bruce pro-
tocols.3 Bicycle exercise echocardiography 
may be performed with an  upright or, ide-
ally, a semi -supine bicycle. The latter allows 
Classical	LFLG	AS
Low‑dose DSELV fl ow reserve present
MPG >30–40 mm Hg 
and AVA ≤1 cm2
AVA >1 cm2
AVAproj >1 cm2 AVAproj ≤1 cm2 AVAproj not measurable
True‑severe AS Pseudo‑severe AS True‑severe AS AV calcium score by MDCT
MPG <30–40 mm Hg 
and AVA ≤1 cm2
LV fl ow reserve absent
Projected AVA if ΔQ >15%–20%
Paradoxical	LFLG	AS
ΔSV <20% ΔSV ≥20% 
 Figure 1  Algorithm for differentiation between true ‑severe and pseudo ‑severe low ‑flow, low ‑gradient aortic stenosis using dobutamine stress echocardiography 
and multidetector computed tomography
 Abbreviations: AS, aortic stenosis; AV, aortic valve; AVA, aortic valve area; Δ, changes from rest to peak stress; DSE, dobutamine stress echocardiography; LFLG, low‑
‑flow, low ‑gradient; LV, left ventricular; MDCT, multidetector computed tomography; MPG, mean pressure gradient; SV, stroke volume
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Interpretation of the test For severe AR without 
symptoms: detection of symptoms with or with-
out contractile reserve. For nonsevere AR with 
symptoms: exercise -induced ischemia ± pulmo-
nary hypertension ± dynamic MR.
Impact on management Surgical aortic valve 
replacement is indicated in patients with se-
vere AR and symptoms revealed by exercise 
testing (class I indication, level of evidence B).6 
The lack of contractile reserve (<5% increase in 
LVEF) was found to predict the development 
of LV systolic dysfunction at follow -up or af-
ter SAVR. Rest and exercise longitudinal func-
tion assessment by tissue Doppler imaging pa-
rameters may reveal early signs of LV systol-
ic dysfunction.3
is recommended to reveal symptoms.3 In pa-
tients with nonsevere AR, an exercise test can 
be performed to exclude symptoms.3
Test parameters	 Modalities	 For the assessment 
of symptoms, ESE is preferred over DSE.
Protocols Supine bicycle exercise is most appro-
priate for the assessment of contractile reserve. 
Images should be acquired at baseline, low work-
load, and peak exercise when using a supine bi-
cycle, and at baseline and immediately postex-
ercise when using a treadmill.
The minimum acquired dataset should include 
2-dimensional (2D) LV views, TR by continuous-
-wave Doppler for estimation of SPAP, and MR 







– 2D LV apical views
– MR and TR color ‑flow Doppler
– TR CW Doppler (for SPAP 
estimation)
– AV CW Doppler (for gradient 
estimation)
– LVOT PW Doppler
– Baseline
 – Low workload
 –  Peak exercise
Symptoms ± drop / no increase in 
LVEF and / or GLS ± regional wall 
motion abnormalities
± SPAP increase ± MR 
development / exacerbation ± 
gradient increase ± projected 
AVA ≤ or >1 cm2 for paradoxical 
LFLG AS
Severe AS with symptoms on 
exertion / SPAP / dynamic MR / lack 
of contractile reserve / exercise‑
‑induced ischemia / noncompliant 
valve
Abbreviations: 2D, 2‑dimensional; CW, continuous ‑wave; ESE, exercise stress echocardiography; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; 
LVOT, left ventricular outflow tract; MR, mitral regurgitation; PW, pulsed ‑wave; SPAP, systolic pulmonary artery pressure; TR, tricuspid regurgitation; others, see FIGURE 1
Table 2	 Criteria	for	abnormal	exercise	stress	echocardiography	findings	and	cutoff	values	for	echocardiographic	markers	of	poor	prognosis	
in	patients	with	asymptomatic	aortic	stenosis	3,7,16
Symptoms Angina, dyspnea, dizziness, syncope and near ‑syncope, fatigue at low workload
Ischemia ≥2‑mm ST ‑segment depression in comparison with baseline
New or worsening regional wall motion abnormalities
Arrhythmias Nonsustained and or sustained ventricular tachycardia
Specific targeted 
features
For high gradient AS: a marked (>18–20 mm Hg) increase in MPG, deterioration of LV systolic function, lack of LV 
functional reserve (increase in LVEF <5%), and exercise SPAP >60 mm Hg
For paradoxical LFLG AS: a marked (up to >30–40 mm Hg) increase in MPG with projected AVA ≤1 cm2, deterioration of LV 
systolic function, and exercise SPAP >60 mm Hg
Abbreviations: MPG, mean pressure gradient; others, see FIGURE 1 and TABLE 1
Table 3	 Therapeutic	decision	‑making	in	patients	with	asymptomatic	severe	aortic	stenosis	undergoing	exercise	stress	echocardiography3,6,15
SAVR is indicated in patients with asymptomatic severe AS and abnormal exercise test with the presence of exercise ‑limiting symptoms (IC).
SAVR should be considered in patients with asymptomatic severe AS and abnormal exercise test showing a reduction in blood pressure below 
baseline values (IIa C)
Patients with asymptomatic severe AS with an exercise ‑induced increase in SPAP or limitation of contractile reserve (increase in LVEF <5%) may 
require closer clinical and echocardiographic monitoring.
If predictors of rapid symptom onset and poor prognosis are present, early SAVR may be justified in patients with asymptomatic severe AS, 
particularly at low surgical risk. These predictors include exercise ‑induced increase in MPG >20 mm Hg.
Stress tests should determine the recommended level of physical activity.
Abbreviations: SAVR, surgical aortic valve replacement; others, see FIGURE 1, TABLE 1, and TABLE 2
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Stress echocardiography should be performed 
when the reported symptoms are dispropor-
tionate to the degree of MR on resting echocar-
diography. This applies both to patients with 
paroxysmal dyspnea (transient pulmonary ede-
ma) and mild / moderate ischemic MR on rest-
ing echocardiography and to asymptomatic pa-
tients with hemodynamically significant mitral 
defect (ie, moderate or severe MR irrespective 
of etiology). When adapting to altered hemody-
namic conditions, elderly patients with heart 
defect often reduce their physical activity, thus 
masking clinical symptoms. With stress echo-
cardiography, it is possible to objectively assess 
exercise capacity and to determine whether re-
ported dyspnea and reduced exercise tolerance 
are related to heart valve disease or comorbid-
ities (lung disease, musculoskeletal disorders, 
anemia) or simply to poor adaptation to exer-
cise (lack of training).2,3 Undoubtedly, the great-
est benefit of exercise testing for the patient is 
the possibility to determine MR severity and es-
tablish the optimal timing for surgery (FIGURE 2). 
For example, in a young asymptomatic female 
patient with hemodynamically significant or-
ganic MR (eg, Barlow syndrome, fibroelastic de-
ficiency) who is planning pregnancy, determina-
tion of specific targeted parameters during ESE 
(PSAP >50 mm Hg, <5% increase in LVEF, <2% 
increase in GLS) guides decision -making about 
early surgical valve repair.
Due to the specific protocol of ESE, the num-
ber of echocardiographic parameters that can be 
obtained during the test is limited. In practice, 
only parameters that can be measured at each 
stage of exercise and that have diagnostic val-
ue for clinical assessment are recorded (FIGURE 3). 
Echocardiographic results are evaluated online 
(2D measurements, Doppler) and offline (LV and 
right ventricular strain measurements). Bicycle 
stress test should be offered to elderly and less 
well -trained individuals, while younger people 
may also be tested using the treadmill. Howev-
er, it is important to note that image acquisi-
tion is easier with a bicycle (2D + Doppler) than 
with a treadmill. The stress test in a patient 
with MR is limited by symptoms or the heart 
rate that allows a legible and reliable record-
ing of echocardiographic parameters (typical-
ly around 100–120 bpm). The diagnostic end-
points as well as criteria for test termination 
are summarized in TABLE 4.
The interpretation of echocardiographic pa-
rameters depends on the etiology of MR and 
concomitant resting clinical symptoms. In 
symptomatic patients with a moderate degree 
of organic MR at rest, an increase in MR sever-
ity (≥1 grade), dynamic pulmonary hyperten-
sion (SPAP >60 mm Hg), absence of LV con-
tractile reserve (5% increase in LVEF, <2% in-
crease in GLS), and a limited right ventricular 
contractile reserve (tricuspid annular plane 
stress echocardiography in mitral regurgita‑
tion Due to the presence of a dynamic compo-
nent in valve disease, a full clinical assessment of 
a patient with acquired valvular disease should 
in principle be carried out both at rest and dur-
ing exercise. The dynamic component is partic-
ularly evident in MR. On the one hand, chang-
es in the function of the LV and subvalvular ap-
paratus during exercise (exercise -induced asyn-
chrony, ischemia, changes in LV shape) can lead 
to alterations in the degree of valvular leak-
age. On the other hand, the progression of MR 
leads to an elevation of pulmonary pressure by 
increasing the left atrial volume and pressure 
overload. For this reason, in the majority of pa-
tients with MR, exercise testing is the most op-
timal modality.1,2 Owing to its pharmacodynam-
ic profile (vasodilatory effect), dobutamine is 
not an appropriate stressor because it can lim-
it functional regurgitation, making it difficult 
to interpret test results. However, DSE may be 
used in ischemic MR when it is important to as-
sess not only mitral valve (MV) leakage but also 
contractile reserve or ischemia in the posterior, 
inferior, and lateral segments (circumflex and 
right coronary artery territory) as well as pap-
illary muscle function. Improved contractility 
and valve sealing at a low dobutamine dose fol-
lowed by deterioration and unsealing at a high 
dose (a biphasic response) indicates the need for 
revascularization in this area.
Symptoms, ΔBP, exercise tolerance
Valve
Δ >10–13 mm2 EROA
Establishing 
a relationship 
of symptoms with MR
Left	ventricle
Δ <5% LVEF 
(no contractile reserve)






ΔE/e’ (LV fi lling pressure)
PH (SPAP >60 mm Hg)
Determination of optimal 
timing for surgery
Discordance between 
symptoms and MR severity
Asymptomatic 






change in blood pressure; others, see FIGURE 1 and TABLE 1
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the MV after repair (when iatrogenic function-
al MS is suspected).3,6,17
The first group of patients with indications for 
SE comprises symptomatic individuals with rest-
ing echocardiography findings suggesting non-
significant MS (ie, MV area [MVA] >1.5 cm2). Dur-
ing SE, MV impaired compliance to the stress-
-induced increase in flow may result in a signifi-
cant rise in mean diastolic gradient (MDG).
The second group with indications for SE in-
cludes patients without symptoms or with atyp-
ical symptoms despite the MVA suggesting he-
modynamically significant MS, in whom stress 
testing may provoke symptoms. The test is indi-
cated when the MVA is lower than 1.5 cm2 and 
higher than 1 cm2 in patients planning pregnancy 
or referred for major surgery and when the MVA 
is lower than 1 cm2 in the remaining patients.
In patients after MV replacement or repair, 
SE is typically indicated when MS symptoms are 
present and the resting MDG is about 5 mm Hg or 
slightly higher. Symptomatic patients after surgi-
cal repair of functional MR (typically after under-
sized rigid ring annuloplasty) constitute a specific 
subgroup. In these patients, systolic LV dysfunc-
tion may result in low flow at rest. Therefore, SE 
should be considered already at an MDG exceed-
ing >3 mm Hg,3 as it may unmask functional MS.
The preferred SE modality is supine bicycle 
exercise. Tricuspid regurgitation velocity for es-
timation of SPAP and mitral valve for the mea-
surement of MDG are recorded with continuous-
-wave Doppler at at different stages of ESE. If 
dedicated equipment is unavailable, a standard 
exercise test (bicycle, treadmill) may be used, 
systolic excursion <19 mm) are all parame-
ters of poor long -term prognosis. On the oth-
er hand, in patients with severe organic MR 
without symptoms, the evaluation should fo-
cus mainly on the presence of clinical symp-
toms (dyspnea), dynamic pulmonary hyper-
tension (SPAP >60 mm Hg), and LV contrac-
tile reserve, without the need to assess the de-
gree of MR. An increase in effective regurgitant 
orifice area (EROA), which is usually observed 
in these patients during exercise, has no prog-
nostic value.1
In patients with ischemic MR and LV systol-
ic dysfunction, an exercise -induced increase in 
EROA of more than 13 mm2 indicates advanced 
postinfarction LV remodeling and may guide 
the decision on simultaneous revasculariza-
tion and MV annuloplasty. On the other hand, 
the reduction of EROA or complete sealing of 
the valve after exercise confirms the presence 
of contractile reserve and the absence of isch-
emia in the posterior, inferior, and lateral wall, 
which indicates good prognosis. The most com-
mon indications for stress testing with regards 
to MR etiology are summarized in TABLE 5.
stress echocardiography in mitral stenosis 
Stress echocardiography is indicated in pa-
tients with discordance between clinical symp-
toms and the degree of MS on resting echocar-
diography. It not only allows a more accurate 
hemodynamic evaluation of native MV dis-
ease but also a dynamic assessment of both 
MV prosthesis (when obstruction or patient–
prosthesis mismatch [PPM] is suspected) and 
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Figure 3  Exercise test protocol using a bicycle ergometer or treadmill in a patient with mitral regurgitation. Left ventricular global and regional function and 
severity of mitral regurgitation are monitored throughout the test. RV function, RVSP, LV strain, and EROA are assessed at baseline and at peak exercise.
 Abbreviations: ECG, electrocardiogram; RV, right ventricular; others, see FIGURE 1, TABLE 4, and FIGURE 2
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by the different models and sizes of valves that 
cause varying degrees of flow obstruction. When 
prosthetic valve dysfunction is suspected, trans-
thoracic echocardiography complemented by 
transesophageal examination may be insuffi-
cient.6,18 Fluoroscopy, and sometimes comput-
ed tomography, may be helpful in patients with 
a mechanical prosthetic valve.10 Stress echocar-
diography may provide additional diagnostic val-
ue. The current recommendations of the Europe-
an Association of Cardiovascular Imaging and 
American Society of Echocardiography provide 
guidelines for applications and performance of 
SE in patients with prosthetic valve.3 The test 
is indicated when there is discordance between 
the patient’s symptomatic status and transtho-
racic echocardiography and / or transesophageal 
echocardiography findings. In patients with no 
or mild symptoms, the preferred modality is ESE 
with semi -supine bicycle. In patients with mod-
erate or severe symptoms, low -dose DSE (up to 
20 μg/kg/min) is recommended.
Stress echocardiography is used to diagnose 
prosthetic valve stenosis or PPM (when the size 
of the implanted valve is too small) in patients 
with a mildly elevated transprosthetic gradient 
at rest. A marked increase in transprosthetic gra-
dient during SE (by >20 mm Hg in the aortic po-
sition and by >10 mm Hg in the mitral position) 
indicates prosthesis stenosis or PPM, especial-
ly at a simultaneous rise in SPAP (>60 mm Hg). 
Another important indication for SE with do-
butamine is the assessment of aortic prosthe-
sis at low cardiac output to differentiate true 
with echocardiographic assessment limited to 
baseline and postexercise. Alternatively, a DSE 
with a maximum infusion rate of 20 µg/kg/min 
can be performed. Due to the specificity of dobu-
tamine’s action, only MDG is assessed.3,17
An SPAP exceeding 60 mm Hg on exertion is 
considered a marker of hemodynamically sig-
nificant MS. The criteria for MDG assessment 
are presented in TABLE 6.
stress echocardiography assessment of 
the tricuspid valve Assessment of TR dur-
ing exercise is used for evaluating the severity 
of left heart valve diseases and their hemody-
namic consequences. Semi -supine bicycle exer-
cise is the preferred modality allowing the esti-
mation of SPAP by TR assessment. Transtricus-
pid pressure gradient should be recorded at ev-
ery stage of the stress test in the assessment of 
AS and AR as well as MS and MR.7 An exercise-
-induced SPAP higher than 60 mm Hg is a pre-
dictor of poor prognosis.7 It is important to re-
cord TR jet velocity by continuous -wave Dop-
pler at low workload, because the increase in 
SPAP from low workload is a marker of more 
significant hemodynamic consequences of valve 
disease.3 Importantly, exercise SPAP is not in-
cluded in the diagnostic criteria of pulmonary 
hypertension.
stress echocardiography in patients with 
prosthetic valve The evaluation of prosthetic 
valve function usually requires extensive clinical 
experience. The diagnostic workup is hindered 
Table 5 	 The	most	frequent	indications	for	exercise	testing	in	patients	with	mitral	regurgitation	depending	on	etiology
Functional	MR Organic	MR
Ischemic MR: assessment of indications for simultaneous myocardial 
revascularization and mitral valve repair / replacement
Asymptomatic patients, assessment of MR severity, determination 
of optimal timing for mitral valve surgery
HCM: assessment of MR severity and indications for concomitant MR 
repair / replacement
Asymptomatic patients before planned pregnancy, assessment of MR 
severity, determination of optimal timing for mitral valve surgery
Diagnostic workup of paroxysmal nocturnal dyspnea and low exercise 
tolerance in patients with moderate MR
Symptomatic patients with moderate MR, assessment of MR severity 
and exercise tolerance as well as the etiology of dyspnea
Abbreviations: HCM, hypertrophic cardiomyopathy; others, see TABLE 1
Table 4	 Diagnostic	endpoints	and	criteria	for	test	cessation	in	patients	with	mitral	regurgitation
Diagnostic	endpoints Criteria	for	test	cessation
Maximum dobutamine dose (simultaneous MR and contractile 
reserve assessment)
Symptoms: muscle fatigue, dyspnea, angina
Maximum tolerated workload Ischemia (ST ‑segment depression ≥2 mm compared with baseline)
Target heart rate Systemic arterial hypertension (220/120 mm Hg) or symptomatic hypotension 
( >40 mm Hg decrease)
Pulmonary hypertension (RVSP >60 mm Hg) New regional contractility abnormalities
Severe MR Arrhythmia (VT, SVT, AF, multifocal ventricular ectopy)
Abbreviations: AF, atrial fibrillation; RVSP, right ventricular systolic pressure; SVT, sustained ventricular tachycardia; VT, ventricular tachycardia; others, see TABLE 1
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value, and the increase is more pronounced in 
the apical than basal segments. In patients with 
AS, there is no or mild increase in GLS (up to 
one -tenth of the baseline value),19 which corre-
lates with abnormal exercise test result.20 Basal 
longitudinal strain during exercise of less than 
–18% is associated with worse prognosis.2 1 Pre-
liminary observations also indicate the useful-
ness of LV global work index in patients with 
AS. Global work index is a secondary param-
eter estimated based on LV pressure–strain 
loops calculated from speckle tracking echo-
cardiographic data.
In patients with asymptomatic primary MR, 
the exercise -induced increase in GLS by 2% or 
higher can be used as a marker of LV contrac-
tile reserve, which was associated with better 
2-year prognosis.2 2
Stress echocardiography protocol with image 
acquisition for speckle tracking–based deforma-
tion analysis should include 3 apical LV views, 
optimized for full chamber -wall registration 
with a frame rate exceeding 40 Hz (optimally, 
60–80 Hz) at rest and peak stress.
The use of contrast agents to improve SE imag-
ing of valve disease is limited to the assessment 
of regional wall motion. In these cases, commer-
cially available transpulmonary contrast agents 
may be used to improve endocardial border de-
lineation. Contrast agents are not recommend-
ed to enhance the Doppler spectrum, especial-
ly during exercise. In the lack of sufficient op-
erator experience, this may lead to inaccuracies 
in border detection.
In conclusion, exercise measurement of GLS 
in the setting of VHD may be practiced in expe-
rienced centers in asymptomatic or mildly symp-
tomatic patients with severe AS or primary MR 
with preserved LV function at rest. The use of 
novel techniques in SE assessment of other valve 
diseases should be investigated in future studies.
stress echocardiography before noncardiac 
surgery in patients with valvular heart dis‑
ease Noninvasive cardiovascular tests consti-
tute a part of preoperative cardiovascular risk as-
sessment. Patients with VHD who are referred 
for noncardiac surgery are at higher risk of car-
diovascular morbidity and mortality. Therefore, 
echocardiography should be performed before 
noncardiac surgery in any patient suspected for 
VHD to confirm the diagnosis and assess disease 
severity. Patients with symptomatic severe AS, 
symptomatic hemodynamically significant MS, 
or MS with an SPAP exceeding 50 mm Hg re-
quire valve replacement or percutaneous coro-
nary intervention before elective noncardiac sur-
gery. Noncardiac surgery is safe in asymptom-
atic patients with asymptomatic severe MR or 
AR and preserved LV function. The presence of 
symptoms and LV dysfunction is associated with 
a mild increase in perioperative risk; however, 
from pseudo -stenosis or mismatch. Indications 
for DSE include low flow rate (stroke volume in-
dex <35 ml/m2), a relatively low gradient, and 
small effective orifice area (EOA; <1 cm2), a small 
indexed EOA (<0.85 cm2/m2), and abnormal 
Doppler velocity index (<0.35). In patients with 
pseudo -stenosis or mismatch, a dobutamine-
-induced increase in the valve EOA (>0.3 cm2) 
with no or minimal elevation in gradients is 
observed. On the other hand, in true stenosis, 
a marked increase in gradient is noted with no 
or minimal increase in EOA (<0.3 cm2). Differ-
entiation is limited by the lack of an increase in 
the transprosthetic flow of at least 20%.
Novel quantitative techniques for stress 
echocardiography in valve heart disease 
In recent decades, practical experience in ad-
vanced techniques for quantitative assessment 
of myocardial function has considerably increased, 
especially regarding the measurement of GLS. 
Also 3-dimensional (3D) echocardiography has 
been increasingly widely used for a more accurate 
measurement of cardiac volumes and other param-
eters such as true anatomical area of the LVOT. 
However, these methods are rarely applied in SE 
protocols. Despite a significant progress in trans-
thoracic imaging quality, 3D echocardiography 
does not always provide sufficient endocardial 
border visualization, especially at peak stress of 
dobutamine or exercise protocols. The clinical 
significance of stress parameters obtained using 
3D echocardiography has not been elucidated. 
The simplest SE protocol incorporating this mo-
dality should include additional full -volume regis-
trations of the LV with a refresh rate of more than 
15 volumes/s at rest and peak stress.
The preliminary clinical experience with GLS 
measurement is limited to patients with as-
ymptomatic AS assessed for early markers of 
myocardial dysfunction, which are potentially 
useful to predict prognosis or guide referral for 
surgery. In healthy individuals, GLS increases 




Native MV stenosis Absolute MDG value (depending on stress test):
>15 mm Hg (ESE)
>18 mm Hg (DSE)
Suspicion of PPM or prosthesis 
dysfunction
ΔMDG (depending on recommendations):
>10 mm Hg3
>12 mm Hg17
Functional MS after MV repair ΔMDG:
>7 mm Hg
Abbreviations: Δ, changes from rest to peak stress; MDG, mean diastolic gradient; MS, mitral 
stenosis; MV, mitral valve; PPM, patient–prosthesis mismatch; others, see FIGURE 1 and TABLE 1
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valvular repair is rarely performed before non-
cardiac procedures.6
The preoperative management of VHD pa-
tients who do not fulfill the above criteria is 
similar to that in the  general population. 
When choosing appropriate diagnostic tests 
(eg, stress echocardiography) for preoperative 
evaluation, one should consider individual func-
tional capacity, clinical risk factors, and surgical 
risk depending on the type of surgery. The clin-
ical risk factors include ischemic heart disease, 
heart failure, stroke or transient ischemic at-
tack, renal dysfunction, and diabetes mellitus 
requiring insulin therapy. Surgical risk accord-
ing to the type of surgery is estimated as low -risk 
(<1%; eg, eye surgery), intermediate -risk (1%–
5%; eg, cholecystectomy), and high -risk (>5%; 
eg, aortic surgery).23
Stress echocardiography is recommended 
before high -risk surgery in patients with poor 
(<4 metabolic equivalents) functional capaci-
ty and more than 2 clinical risk factors (class I, 
level of evidence C). It may also be considered 
in patients with 1 or 2 clinical risk factors (class 
IIb, level of evidence C). A similar recommenda-
tion is made for intermediate -risk surgical pa-
tients. Considering the low risk of cardiovascu-
lar events in patients referred for low -risk sur-
gery, routine screening with noninvasive stress 
tests is not recommended in this group (class III, 
level of evidence C).2 3
Exercise stress echocardiography is the pre-
ferred modality. In patients with limited ability 
to exercise, DSE is usually performed.23-25 As SE 
has a high negative predictive value, negative out-
come is associated with a very low cardiovascular 
risk in patients undergoing noncardiac surgery.
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